Siglec-L1 Inhibitors
Siglec-L1 inhibitors are a class of chemical compounds designed to specifically block the activity of Siglec-L1, a member of the sialic acid-binding immunoglobulin-like lectins (Siglecs) family. Siglec-L1, like other Siglecs, plays a critical role in immune system regulation by recognizing and binding to sialic acid-containing glycans on cell surfaces. This interaction is important for modulating immune cell activity, as Siglec proteins often serve as inhibitory receptors that regulate immune responses, maintaining a balance between immune activation and suppression. Siglec-L1 is believed to participate in cellular recognition processes and communication within the immune system, influencing how immune cells interact with one another and with other cells in the body. Inhibitors of Siglec-L1 are designed to disrupt these interactions by targeting the specific regions of the protein responsible for recognizing sialic acid ligands.
The development of Siglec-L1 inhibitors relies on a thorough understanding of the protein's structure, particularly the domains responsible for sialic acid binding and its interactions with other cellular components. Researchers use techniques such as X-ray crystallography, molecular docking, and computational modeling to identify these key binding sites and design small molecules or peptides that can selectively block Siglec-L1's activity. These inhibitors prevent Siglec-L1 from engaging with its ligands, thereby altering its regulatory influence on immune cell signaling. Biochemical assays are employed to evaluate the efficacy, binding affinity, and specificity of these inhibitors, ensuring they effectively target Siglec-L1 without affecting related proteins in the Siglec family. By inhibiting Siglec-L1, researchers aim to explore its precise role in immune modulation, cell communication, and how it affects cellular interactions in immune processes. The study of Siglec-L1 inhibitors helps to uncover the broader significance of Siglecs in maintaining immune balance and their impact on cellular recognition mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin might downregulate Siglec-L1 expression by inhibiting the activity of specific transcription factors such as NF-κB, which are known to play a role in the gene's transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
By activating sirtuin proteins, resveratrol could lead to histone deacetylation, which might decrease the transcriptional activity of the Siglec-L1 gene. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, genistein could downregulate the phosphorylation state of proteins involved in the signaling pathways that drive Siglec-L1 expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin might inhibit phosphorylation cascades, leading to a decrease in the activation of transcription factors responsible for Siglec-L1 expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane could inhibit the activation of the NF-κB pathway, which might lead to a decrease in Siglec-L1 gene transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate could inhibit several cellular signaling pathways, leading to a downregulation of transcription factors that govern Siglec-L1 gene expression. | ||||||
Indole-3-carbinol | 700-06-1 | sc-202662 sc-202662A sc-202662B sc-202662C sc-202662D | 1 g 5 g 100 g 250 g 1 kg | $39.00 $61.00 $146.00 $312.00 $1032.00 | 5 | |
By altering estrogen receptor signaling, indole-3-carbinol might decrease transcriptional activation of the Siglec-L1 gene. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram might inhibit the proteasomal degradation of IκB, leading to the sequestration of NF-κB and a consequent reduction in Siglec-L1 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid could lead to the acetylation of histones associated with the Siglec-L1 gene, reducing the transcriptional efficiency of the gene. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate could inhibit histone deacetylation, leading to a tightly packed chromatin structure at the Siglec-L1 locus, thereby reducing its transcription. | ||||||